545 results on '"Kwekkeboom, Jaap"'
Search Results
202. 936 Distinct intrahepatic immunological environment in chronic viral hepatitis analysed by flow cytometry of fine-needle-aspiration-biopsies
203. Assay of cholesterol 7α-hydroxylase activity in rat hepatocytes in primary monolayer culture
204. Feedback inhibition of bile acid synthesis in cultured pig hepatocytes
205. Comparison of taurocholate accumulation in cultured hepatocytes of pig, rat and man
206. Regulation of cholesterol metabolism in the liver in vivo and in vitro
207. Does the donor mannose-binding lectin genotype really predict the risk of bacterial infections after liver transplantation?
208. GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cells ex vivo.
209. INTRAVENOUS IMMUNOGLOBULINS MODULATE THE BIDIRECTIONAL INTERACTION BETWEEN DENDRITIC CELLS AND NATURAL KILLER CELLS RESULTING IN REDUCED ALLOGENEIC T-CELL PRIMING.
210. PD-L1, Galectin-9 and CD8+tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
211. Long-lived intragraft donor leukocytes or relocated donor hematopoietic stem/progenitor cells can cause long-term hematopoietic chimerism after liver transplantation.
212. AFTER LIVER TRANSPLANTATION FUNCTIONAL DONOR DENDRITIC CELLS MIGRATE VIA THE BLOOD CIRCULATION INTO THE RECIPIENT.
213. HUMAN HEPATIC REGULATORY T CELLS DETACH FROM THE LIVER GRAFT AND CIRCULATE IN RECIPIENTS AFTER TRANSPLANTATION: IMPLICATION FOR TOLERANCE?
214. DECLINE IN NUMBERS AND MATURATION STATUS OF CIRCULATING DENDRITIC CELLS AFTER LIVER TRANSPLANTATION.
215. Mycophenolic acid is a potent inhibitor of the expression of tumour necrosis factor- and tumour necrosis factor-receptor superfamily costimulatory molecules.
216. Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells.
217. Minimal Development of Liver Fibrosis in Adult Tolerant Liver Transplant Recipients Late After Immunosuppressive Drug Weaning and Transplantation.
218. Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers.
219. Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients.
220. The biological process of lysine‐tRNA charging is therapeutically targetable in liver cancer.
221. Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis.
222. HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis.
223. Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules.
224. Engaging the immune system in the fight against cancer
225. Dichotomal functions of phosphorylated and unphosphorylated STAT1 in hepatocellular carcinoma.
226. Donor‐specific anti‐HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation.
227. Rejection and Tolerance after Liver Transplantation
228. Cytomegalovirus-Induced Expression of CD244 after Liver Transplantation Is Associated with CD8+ T Cell Hyporesponsiveness to Alloantigen.
229. Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function.
230. Differential Sensitivities of Fast-and Slow-Cycling Cancer Cells to Inosine Monophosphate Dehydrogenase 2 Inhibition by Mycophenolic Acid.
231. Human secondary lymphoid organs typically contain polyclonally-activated proliferating regulatory T cells.
232. Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells.
233. Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome.
234. Combined antiviral activity of interferon-α and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing.
235. Modulation of the cellular immune system by intravenous immunoglobulin
236. Dexamethasone transforms lipopolysaccharide-stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin-10 production in T cells.
237. FRI488 - Modelling liver tumor organoids and cancer-associated fibroblasts interaction reveals the robust effects of stromal niche in cancer nurturing and treatment resistance.
238. AS049 - Identification of a panel of safe immunogenic antigens for therapeutic vaccination strategies in hepatocellular carcinoma.
239. Expression of Cancer Testis Antigens in Tumor-Adjacent Normal Liver Is Associated with Post-Resection Recurrence of Hepatocellular Carcinoma.
240. Regulation of intra-tumoral T cell immunity in liver cancer
241. T-cell inhibitory capacity of hyperimmunoglobulins is influenced by the production process.
242. Potential Immune Biomarkers in Gastrointestinal Cancers: Immune Inhibitory Molecules, Lymphocytes and Tumor Antigens
243. FRI484 - TIGIT and PD1 dual checkpoint blockade restores functionality of tumor-infiltrating T cells in hepatocellular carcinoma.
244. New insigths in immune regulation after liver transplantation
245. Determinants of complications in liver transplant patients
246. Approaches to Optimize Immunosuppression after Liver Transplantation
247. Hepatic NK cells in liver transplantation
248. Intravenous immunoglobulins after liver transplantation
249. Immunomodulation after liver transplantation; a role for dendritic cells
250. High-dose intravenous immunoglobulin does not reduce the numbers of circulating CD14+CD16++ monocytes in patients with inflammatory disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.